• Explore /
  • Poster
  • / Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma <em>in vitro</em> and <em>in vivo.</em>

Tumor treating fields (TTFields) in combination with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo.

Abstract Poster

Authors

null

Wyatt Potter

Novocure Inc, New York, NY

Wyatt Potter , Shiri Davidi , Sara Jacobovitch , Anna Shteingauz , Catherine Tempel-Brami , Einav Zeevi , Eyal Dor-On , Rosa S Schneiderman , Tali Voloshin , Itai Tzchori , Adi Haber , Moshe Giladi , Adrian Kinzel , Uri Weinberg , Yoram Palti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Translational Research

DOI

10.1200/JCO.2022.40.4_suppl.464

Abstract #

464

Poster Bd #

D3

Abstract Disclosures

Similar Posters

First Author: Sukeshi Patel Arora

First Author: Robert J. Kinders

First Author: Mehreen Aftab

First Author: Graeme Currie